Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sunnybrook Health Sciences Centre
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Provision of written informed consent
Diagnosis of major depressive disorder, currently depressed as determined by DSM-IV diagnostic criteria (confirmed using the MINI)
Both females and males, aged 18 to 65 years
Outpatient status
Female patients of childbearing potential must have a negative urine human chorionic gonadotropin (hCG) test at enrolment and must be taking or willing to take some acceptable form of birth control during the course of the study if they are or plan to be sexually active
A grade 8 English comprehension, the ability to understand and comply with the requirements of the study and capable of providing informed consent
17-item Hamilton Depression Rating Scale (HAM-D) score of 14-22 at screening and at baseline
You may not be if
Diagnosis of a past hypomanic, manic or mixed state.
Current or past psychotic symptoms
Substance or alcohol dependence at enrolment (except dependence in full remission, and except for caffeine or nicotine dependence), as defined by DSM-IV criteria
Opiates, amphetamine, barbiturate, cocaine, cannabis, or hallucinogen abuse by DSM-IV criteria within 4 weeks prior to enrolment
Any pervasive developmental disorder (according to DSM-IV criteria)
Diagnosis of dementia (according to DSM-IV criteria)
Is at significant risk for suicide, as defined by a score of ≥ 2 on the suicide item of the MADRS, any suicidal ideation with intent or a plan within the 3 months prior to study entry or in the opinion of the investigator.
Any history of lifetime suicide attempts
Current treatment with an antidepressant medication
Treatment with an antipsychotic, mood stabilizer or other psychoactive medication within a period of 5 half-lives of the medication prior to baseline visit
Known intolerance, hypersensitivity or lack of response to duloxetine as judged by the investigator
A history of treatment resistant depression (defined as 2 or more failed lifetime trials of antidepressant medication as judged by the investigator)
Currently undergoing psychotherapy that was initiated within the past 3 months
Significant medical condition that would contraindicate the use of duloxetine or that is untreated and would need urgent attention (as determined by treating physician)
Medical conditions that would significantly affect absorption, distribution, metabolism, or excretion of duloxetine
Unstable or inadequately treated medical illness (e.g. congestive heart failure, angina pectoris, hypertension) as judged by the investigator
Any clinically significant deviation from the reference range in clinical laboratory test results as judged by the investigator
Pregnancy (or female of child-bearing age not using adequate contraception) or lactation
A positive β-hCG test at enrolment
Involvement in the planning and conduct of the study
Previous enrolment or randomisation of treatment in the present study
Participation in another drug trial within 4 weeks prior enrolment into this study or longer in accordance with local requirements